Skip to main content
. 2018 Jun 29;119(3):330–338. doi: 10.1038/s41416-018-0157-z

Fig. 1.

Fig. 1

CD31 immunohistochemistry staining for intratumoural MVD assessment: MVDhigh (a) and MVDlow (b) pOC samples; MVDhigh (c) and MVDlow (d) rOC samples. ×400 magnification; MVD count among primary and recurrent tumours (box plot (e) and scatter plot (f))